Advanced heart failure treated with continuous-flow left ventricular assist device.
By Mark S. Slaughter, Joseph G. Rogers, C. Milano, Stuart D. Russell, John V. Conte, D. Feldman, Benjamin Sun, A. Tatooles, Reynolds M Delgado, J. Long and 4 more. New England Journal of Medicine, 2009
2,875 citations recorded by the source corpus.
Subfields: Biomedical Engineering, Surgery
View Paper: https://www.semanticscholar.org/paper/3f1acb22acedf0a987ba6e0906a9bd10cb288b60
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Surgery
Citations in the corpus
- Narrative Review (2012, background): “Left ventricular assist devices have been demonstrated to increase survival and improve the quality of life and functional capacity of patients with refractory HF.(125) Most currently available LVADs are surgically implanted and require cardiopulmonary bypass to implant.”
- 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, background): “MRI is reasonable when assessing myocardial infiltration or scar IIa B (286-288)”
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 (2012, background): “Ventricular assist devices may ultimately become a more general alternative to transplantation, as current 2- to 3-year survival rates in carefully selected patients receiving the latest continuous flow devices are much better than with medical therapy only.(254,255) Patients receiving these devices”
- A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure (2017, methodology): “Panel A is adapted from Slaughter et al.(1) LVAS denotes left ventricular assist system.”